1.Antiatherogenic effect of piperlonguminine on experimental atherosclerosis in rabbits.
Chun-Jie MA ; Gereltu BORJIHAN ; Hurilebagen ; Tegexi ; Surina
China Journal of Chinese Materia Medica 2008;33(4):436-469
OBJECTIVETo investigate of antiatherogenic effect and possible mechanisms of piper longuminine.
METHODThe atherosclerotic model was established by the hypercholesterol feeding rabbits. Male Mew Zealand rabbits were randomly divided into five groups: normal group, model group, the high-dose (5 mg x kg(-1) x d(-1)) and low-dose (2.5 mg x kg(-1) x d(-1) group of piperlonguminine, and simvastatin group (5 mg x kg(-1) x d(-1)). All the rabbits were fed for 60 days. Blood samples were taken from the ear edge vein of rabbits in the day before the experiment, and in the days of 20, 40 and 60 days after the experiment, respectively. All the rabbits were fasted for at least twelve hours before the blood was taken. The blood serum were analyzed for total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C). The blood serum of the 60th day were also analyzed for superoxide dismutase (SOD), malondialdehyde (MDA) and nitric oxide (NO). At last, the pathological observation of aorta and heart samples were carried out.
RESULTCompared with those in model group, the TC, TG and LDL-C levels were reduced (P < 0.05) and the HDL-C was raised in the piperlonguminine group; also, the serum SOD and NO level was raised (P < 0.05), MDA level was reduced in the piperlonguminine group (P < 0.05). Area percentage of aorta plaque was reduced (P < 0.01) in the piperlonguminine group. The aorta and heart injury was abated and coronary artery angusty extent was markedly abatement (P < 0.01). The results of observation through transmission electron microscope (TEM) indicated that the fine structure of aortal pathological degree was markedly abated.
CONCLUSIONThe piperlonguminine could inhibit the atherogenesis formation and development, which might be due to regulating the lipid metabolism and enhancing the antioxidation.
Animals ; Atherosclerosis ; blood ; chemically induced ; drug therapy ; pathology ; Cholesterol ; blood ; Cholesterol, HDL ; blood ; Cholesterol, LDL ; blood ; Dioxolanes ; pharmacology ; Male ; Malondialdehyde ; blood ; Nitric Oxide ; blood ; Rabbits ; Superoxide Dismutase ; blood ; Triglycerides ; blood
2.Prediction and validation of the mechanism of Zadi-5 pill in protecting myocardial ischemia-reperfusion injury
WURIGA ; WEILISI ; WURILAGA ; SUSI ; ARUHAN ; Lijun TONG ; BUTUYA ; HURILEBAGEN
China Pharmacy 2024;35(4):442-448
OBJECTIVE To explore the mechanism of Zadi-5 pill in improving myocardial ischemia-reperfusion injury (MIRI). METHODS The targets and pathways of potential effects of Zadi-5 pill improving MIRI were screened based on the network pharmacology. Seventy-two rats were randomly divided into model group, sham operation group, Danshen group [Compound danshen dripping pills 80 mg/(kg·d)] and Zadi-5 pill high-dose, medium-dose and low-dose groups [1.6, 0.8, 0.4 g/(kg·d)], with 12 rats in each group. The rats in each group were given corresponding drugs intragastrically, once a day, for 14 consecutive days. After the last administration, MIRI model was established by ligating the anterior descending branch of left coronary artery in rats, while rats in the sham operation group were threaded without ligation. The contents of creatine kinase (CK), lactate dehydrogenase (LDH), aspartate transaminase (AST), cardiac troponin T (CTn-T), apoptotic rate of cardiomyocyte, phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), B-cell lymphoma-2 (Bcl-2), Bcl-2 related X protein (Bax) and caspase-3 in myocardial tissue were detected in each group after modeling; the morphological changes of myocardial tissue were observed. RESULTS A total of 177 active ingredients and 220 targets of Zadi-5 pill were obtained, including 51 targets involved in improving myocardial ischemia; the core target of Zadi-5 pill improving MIRI was AKT1, including PI3K-Akt, endoplasmic reticulum and hypoxia-inducible factor-1. Compared with model group, the contents of CK, LDH, AST and CTn-T, the apoptotic rate of cardiomyocyte as well as the protein expressions of caspase-3 and Bax were significantly decreased in Danshen group and Zadi-5 pill high-dose group (P<0.05 or P<0.01), while the protein expressions of PI3K, Akt and Bcl-2 in myocardial tissue were significantly increased (P<0.05 or P<0.01), respectively; the myocardial histopathological changes were significantly improved. The above indicators were improved to varying degrees in Zadi-5 pill low-dose and medium-dose groups, too. CONCLUSIONS Zadi-5 pill may inhibit apoptosis by activating the PI3K-Akt signaling pathway, thus playing a role in improving MIRI.